Aseem Rastogi and Pantazis Deligiannis talk about two technical results from ICSE 2025 on using large language models (LLMs) for safe low-level programming. The results demonstrate LLMs inferring machine-checkable memory safety invariants in legacy C code and how LLMs assist…
Gagan Bansal introduces a transformative update to the AutoGen framework that builds on user feedback and redefines modularity, stability, and flexibility to empower the next generation of agentic AI research and applications.
John Langford talks about a new transformer architecture that generates compact belief states for goal-conditioned planning, enhancing planning algorithms' efficiency and effectiveness.
Jianwei Yang introduces Magma, a new multimodal agentic foundation model designed for UI navigation in digital environments and robotics manipulation in physical settings.
Marwin Segler addresses chemical synthesis in drug discovery with a learning-to-rank framework that integrates AI-based models, significantly boosting prediction accuracy and preferred by chemists.
This panel explores the transformative potential of generative AI in learning the language of nature and patients for precision health, from proteins to medical imaging, from electronic medical records to home health monitoring.
Hoifung Poon introduces an agenda in precision health, utilizing generative AI to pretrain high-fidelity patient embeddings from multimodal, longitudinal patient journeys. This approach unlocks population-scale real-world evidence, optimizing clinical care and accelerating biomedical discovery.
| Swadheen Shukla, Jianwei Yang, Reuben Tan, Qianhui Wu, and Jianfeng Gao
Explore Magma, a foundation model that can empower AI assistants to interpret environments, plan actions, and execute tasks across digital and physical spaces. Now available, learn how it advances the field of agentic AI.
In the news | ConSalud
Microsoft's generative artificial intelligence is making it possible to identify patterns in large populations, structure clinical information and simulate clinical trials, optimizing the development of new treatments.